Avidicure
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avidicure operates in Healthcare & Life Sciences and is based in Oegstgeest. Its latest recorded funding round was a Seed round in April 2025.
Avidicure is a biotechnology company that develops a dual agonistic, multifunctional antibody modality designed to engage immune cells for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avidicure Comparables
Compare Avidicure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revitope Oncology, Inc. | 78% | |
| Biomunex Pharmaceuticals | 78% | |
| Genmab A/S | 73% |
For institutional investors. Book with your work email.
Avidicure Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avidicure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| EQT Life Sciences | Seed |
| V-Bio Ventures | Seed |
| BioGeneration Ventures | Seed |
| Kurma Partners | Seed |
| Curie Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 2720% MoM, from 45 to 1.3K.
- Apr 24, 2025
$50M round led by EQT Life Sciences
For institutional investors. Book with your work email.
Avidicure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avidicure's valuation, stock price, and market status.
Is Avidicure a public or private company?
Avidicure is a private company.
What is the current stock price of Avidicure?
Avidicure is a private company, so its shares have no public market price. Caplight tracks Avidicure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avidicure worth (valuation)?
Valuation information for Avidicure is not publicly available.
Can I buy Avidicure stock?
Avidicure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avidicure's last funding round?
Avidicure's most recent funding round was Seed on April 24, 2025.
Who are the main investors in Avidicure?
Key investors in Avidicure include EQT Life Sciences.
Will Avidicure IPO soon?
No public IPO plans have been announced for Avidicure.
How can I track Avidicure secondary market activity?
Caplight tracks bids, offers, and trades in Avidicure's shares on secondary markets.